ADHD, Neurocore, and a new era in mind control: FDA permits first brain wave test to help assess (and control) the ADHD mind

The U.S. Food and Drug Administration (FDA) allowed on July 15, 2013, the marketing of the first medical device based on brain function to help assess attention-deficit/hyperactivity disorder (ADHD) in children and adolescents 6 to 17 years old.

The device, the Neuropsychiatric EEG-Based Assessment Aid (NEBA) System, is based on electroencephalogram (EEG) technology, which records different kinds of electrical impulses (waves) given off by neurons (nerve cells) in the brain and the number of times (frequency) the impulses are given off each second.

The NEBA System is a 15- to 20-minute non-invasive test that calculates the ratio of two standard brain wave frequencies, known as theta and beta waves. The theta/beta ratio has been shown to be higher in children and adolescents with ADHD than in children without it.

When used as part of a complete medical and psychological examination, the device can help confirm an ADHD diagnosis or a clinician’s decision that further diagnostic testing should focus on ADHD or other medical or behavioral conditions that produce symptoms similar to ADHD.

Here are a few more ADHD important facts:

• So far, ADHD has been diagnosed mainly through subjective observations by parents and teachers, meaning that there really is no standard diagnostic test of ADHD.

• Before NEBA, ADHD tests included meeting the criteria according to the Diagnostics and Statistical Manual of Mental Disorders IV Text Revision (DSM-IV-TR), a behavioral questionnaire, a physical examination (to show there is nothing physically wrong), and IQ and behavioral testing.

• To be diagnosed with ADHD, a kid has to be smart but not perform accordingly.

• NEBA Health of Augusta, Ga., manufactures the NEBA System.

• In support of the de novo petition, the manufacturer submitted data including a clinical study that evaluated 275 children and adolescents ranging from 6 to 17 years old with attention or behavioral concerns. Clinicians evaluated all 275 patients using the NEBA System and using standard diagnostic protocols, including the Diagnostic and Statistical Manual of Mental Disorders IV Text Revision(DSM-IV-TR) criteria, behavioral questionnaires, behavioral and IQ testing, and physical exams to determine if the patient had ADHD. An independent group of ADHD experts reviewed these data and arrived at a consensus diagnosis regarding whether the research subject met clinical criteria for ADHD or another condition. The study results showed that the use of the NEBA System aided clinicians in making a more accurate diagnosis of ADHD when used in conjunction with a clinical assessment for ADHD, compared with doing the clinical assessment alone. (FDA information)

As a consequence of the FDA approval, health care providers and private organizations will be offering the brain wave test.

As discussed in the above video, Neurocore measures the electrical current that drives the brain and shows it on a screen in brain waves. It does not only assess the brain waves or electricity of the ADHD mind but it also controls it. The electrical current of the ADHD brain is amplified and sent to a computer that plays a DVD. As children watch a DVD that they want to watch, if their brain waves go higher, the DVD will stop -- telling the ADHD kid, “stop doing that.” The goal is to achieve a “perfect pattern of focus.” 

Leonardo da Vinci, Galileo Galilei, Thomas Edison, Orville Wright, and Winston Churchill would most likely have all said the same thing: Of course our brain waves and neurons have to work faster. How else would we have been able to accomplish what we did during our life time? (Exploration International).

Would they have chosen to have those brain waves changed into a "perfect pattern of focus"?